XUFN:XETRA:XETRA-db x-trackers MSCI USA Financials UCITS DR (EUR)

ETF | Others |

Last Closing

USD 30.99

Change

-0.49 (-1.56)%

Market Cap

USD 1.16B

Volume

6.45K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.11 (-0.21%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.04 (-0.23%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.15 (-0.55%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.04 (-0.13%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.04 (-0.09%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

-0.38 (-0.27%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.07 (-0.13%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.81 (-0.83%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-5.36 (-0.95%)

USD 80.38B

ETFs Containing XUFN:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 24.18% 93% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.18% 93% A 91% A-
Trailing 12 Months  
Capital Gain 37.46% 93% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.46% 93% A 91% A-
Trailing 5 Years  
Capital Gain 59.54% 80% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 59.54% 80% B- 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 15.75% 88% B+ 85% B
Dividend Return 16.60% 88% B+ 84% B
Total Return 0.85% 59% D- 41% F
Risk Return Profile  
Volatility (Standard Deviation) 23.43% 14% F 26% F
Risk Adjusted Return 70.84% 67% D+ 71% C-
Market Capitalization 1.16B 80% B- 70% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.